Processing inhibition of N-linked sugar chains associated with induction of Fc receptor-mediated phagocytosis in the mouse monocytoid cells

The concanavalin A staining of cellular glycoproteins and thedirect analysis of their sugar chains released by hydrazinolysisrevealed that the processing of N-linked sugar chains of someglycoproteins is suppressed by exposure of mouse monocytoidcells P388D1 to dimethyl sulphoxide, which can induce Fc receptor-mediatedphagocytosis. To elucidate the significance of altered glycosylationin inducing phagocytosis, the effects of exposure of the cellsto processing inhibitors (swainsonine and castanospermine) wereexamined and it was found that the cells are induced to acquirean ability to ingest IgG-coated sheep red blood cells, dependingon the dose of the inhibitors and incubation time. Analysisof the N-linked sugar chains liberated from cellular glycoproteinsby hydrazinolysis confirmed that the processing of the sugarchains is suppressed by the two inhibitors as expected. Sinceno significant alteration was induced in protein synthesis andDNA synthesis after exposure to the inhibitors, it is suggestedthat the altered glycosylation of cellular glycoproteins mayhave some direct role in the induction of Fc receptor-mediatedphagocytosis. The inhibitors did not affect the binding of theIgG-coated red blood cells to Fc receptors on the cells, non-specificphagocytosis of latex beads, and the contents of lysosomal enzymes,ß-glucuronidase and acid phosphatase. These resultssuggest that the glycosylation status of cellular glycoproteinsinfluences some specific processes involved in the ingestionof the ligands bound to Fc receptors. castanospermine macrophages phagocytosis swainsonine     

A missense mutation (G197→A) in theα-l-fucosidase gene of fucosidosis patients leads to loss ofα-l-fucosidase

Fucosidosis is an autosomal recessive lysosomal storage disease resulting from the absence of -l-fucosidase activity. Two natural missense mutations (G¹⁹⁷A) and (A⁸⁶⁰G) within the -l-fucosidase gene have been reported to be homozygous in four patients with fucosidosis. Expression of wild-type and mutated -l-fucosidase cDNAs in COS-1 cells revealed complete deficiency of -l-fucosidase for the G¹⁹⁷A transition and a normal level of enzyme for A⁸⁶⁰G. We therefore conclude that the change of G¹⁹⁷A is responsible for fucosidosis in the patients while A⁸⁶⁰G is a normal polymorphic variant of -l-fucosidase.     

Partial purification of 6-(D-erythro-1',2',3'-trihydroxypropyl)-7,8-dihydropterin triphosphate synthetase from chicken liver.

An enzyme that catalyzes the formation of 6-(D-erythro-1',2',3'-trihydroxypropyl)-7,8-dihydropterin triphosphate (D-erythrodihydroneopterin triphosphate) and formic acid from GTP has been purified about 3700-fold from homogenates of chicken liver. The molecular weight of the enzyme, D-erythrodihydroneopterin triphosphate synthetase (GTP cyclohydrolase), has been estimated to be 125,000 by gel filtration on Ultrogel AcA-34. The enzyme functions optimally between pH 8.0 and 9.2 and is considerably heat-stable. No cofactors or metal ions have been demonstrated to be required for activity; however, the reaction is strongly inhibited by Cu2+ and Hg2+. GTP is the most efficient substrate, with GDP being 1/17 as active and guanosine, GMP, and ATP being inactive. The Km for GTP has been found to be 14 micrometer. Although the overall reaction catalyzed by D-erythrodihydroneopterin triphosphate synthetase from chicken liver is identical with that from Escherichia coli GTP cyclohydrolase, immunological studies show no apparent homology between the two enzymes.     

Partial purification and property of pyridoxine (pyridoxamine)-5′-phosphate oxidase isozymes from wheat seedlings

Isozymes of pyridoxine (pyridoxamine)-5′-phosphate oxidase (EC 1.4.3.5) were isolated from the extract of wheat seedlings by column chromatographies. From DEAE-Sephadex A-50, two fractions having pyridoxine-5′-phosphate oxidase activity were separated by eluting with ~0.075 and ~0.125 m phosphate buffers (pH 8.0). These fractions were further fractionated on a Blue-Sepharose CL-6B column, from which again two activities were eluted by 1.0 m KCl solution. One fraction, designated as E-I, used only pyridoxine 5′-phosphate as substrate, whereas the other, designated as E-II, oxidized not only pyridoxine 5′-phosphate but also pyridoxamine 5′-phosphate with approximately equal rates. The mobility on polyacrylamide disc gel electrophoresis and the substrate specificity of these two fractions were different. Therefore, they were concluded to be isozymes.     

Prostaglandin D2, a potential antineoplastic agent

Cytotoxic actions of various prostaglandins were examined on L1210 mouse leukemia and several human leukemia cell lines, and prostaglandin D₂ (PGD₂) was found most active. PGD₂ exerted a dose dependent inhibition of L1210 cell growth over 3.6 μ$\text{M}$. At 14.3 μ$\text{M}$ growth was completely inhibited, and the number of viable cells remarkably decreased during culture. Microscopically the remaining cells showed degenerative changes with many vacuoles in their cytoplasm. The IC₅₀ value of PGD₂ on L1210 cell growth was calculated to be 6.9 μ$\text{M}$ (2.4 μg/ml), and at this concentration the DNA synthesis in 24 hr cultured cells was also decreased to a half of the level in the control cells. Such growth inhibition by PGD₂ was also found at similar concentrations with several human leukemia cell lines such as NALL-1, RPMI-8226, RPMI-8402, and Sk-Ly-16. Among other prostaglandins tested, PGA₂ showed a comparable, and PGE₂ a less but significant growth inhibitory activity, while PGB₂, PGF_2α and PGI₂ had no such effects on cell proliferation at 14.3 μ$\text{M}$ concentration. These results suggest a potential antineoplastic activity of PGD₂.     

Ultrastructural localization of adenylate cyclase activity in chicken osteoclasts

Using lead citrate as a capture reagent and adenylate-(beta, gamma-methylene) diphosphate (AMP-PCP) as a substrate, we localized adenylate cyclase activity on the non-ruffled border plasma membrane of approximately half of the osteoclasts on trabecular bone surfaces in the tibial metaphyses of chickens fed a low (0.3%)-calcium diet. The enzyme was not detectable in osteoclasts when chickens were fed a normal calcium diet. Activity was observed on the entire plasma membrane of detached osteoclasts that were situated between osteoblasts on the bone surface and blood vessels in the marrow cavity. Detection of activity on detached osteoclasts required the presence of an activator, implying lower levels in these cells than in those with ruffled borders. Staining was greater on the lateral sides of osteoblasts and osteoclasts when they were in contact with each other. Reaction specificity was indicated by the demonstration of stimulation by forskolin, guanylate-(beta, gamma-methylene) diphosphate (GMP-PCP), dimethylsulfoxide, and NaF, inhibition by alloxan and 2',5'-dideoxyadenosine, and absence of activity when sections were incubated in substrate-free medium or when GMP-PCP replaced AMP-PCP as a substrate. The finding of adenylate cyclase in osteoclast plasma membrane provides structural evidence that the adenylate cyclase-cyclic AMP system has a role in regulation of osteoclast cell function. The low-calcium diet appears to have resulted in increased amounts of adenylate cyclase in osteoclasts.     

Effects of mutagens on the clonal lifespan of Paramecium tetraurelia.

There has been interest in the phenomenon that a cell cannot undergo unlimited reproduction under adequate conditions and undergoes senescence. In holotrichous ciliates, Paramecium has a limit of vegetative reproduction without sexual reproduction but Tetrahymena does not always have a limited lifespan. Comparing the two species would increase our knowledge of the mechanism of cellular clonal aging. We previously showed that mutations induced by X-rays shorten clonal lifespan. In this study, we examined whether mutagens shorten the clonal lifespan of Paramecium tetraurelia. P. tetraurelia was exposed to the alkylating agent N-methyl-N'-nitro-N-nitrosoguanidine (MNNG), 0.045 mg/ml, for 30 min. The animal was exposed to MNNG 6 times in total while young (under 80 divisions from the start of a clonal life cycle) or 4 times during the senescent stage. MNNG shortened the clonal lifespan as expressed by the decrease in fission number from 186 +/- 55 (4 cell lines) to 136 +/- 21 (6 cell lines) with the first two treatments but with further exposures the lifespan increased to 182 +/- 15 (5 cell lines). MNNG had no effect when administered at the older age. Exposure of P. tetraurelia to 4-nitroquinoline-N-oxide at 0.021 mg/ml twice for 12 and 15 min at the younger age reduced the mean clonal lifespan from 143 +/- 28 to 125 +/- 21 and the maximum lifespan from 263 +/- 33 to 175 +/- 25.     

Mitotic Arrest in Tobacco Caused by the Phosphoprotein Phosphatase Inhibitor Okadaic Acid

Okadaic acid blocks the cell cycle at early mitosis in suspensioncultures of Nicotiana plumbaginifolia. Nuclear DNA content wasmeasured in treated cells by propidium iodide staining, fluorescencemicroscopy and quantitative analysis of the video image. NuclearDNA levels in inhibited populations showed that cells continuedto progress from G1 phase through S phase and accumulated inG2 phase. Arrested cells in 12 µM okadaic acid had a condensedchromatin configuration and persisting nucleolus similar tonormal early prophase. Progress to early prophase was also indicatedby development of the preprophase band (PPB) of microtubules.PPB microtubules disassembled in 95% of the inhibited cellswith the same timing as in control cells, although the treatedcells did not progress to prometaphase mitotic spindle assemblythat normally precedes PPB breakdown, therefore okadaic acidcan disrupt the normal dependence of PPB disassembly on prometaphasenuclear events and indicates that the normal signal for disassemblymay be an increase in phosphorylation of PPB associated proteins.Okadaic acid at 12 µM caused increased levels of phosphorylatedproteins, in particular those of 108 kDa, 49 kDa, 36 kDa, 33kDa, 31 kDa, but more complex effects on some phosphoproteinswere indicated by reductions in a phosphoprotein of 41 kDa andone of approximately 190 kDa. It is concluded that the mitoticphase of the plant cell cycle is more sensitive than precedingcycle phases to the disruption of protein phosphorylation levelsby okadaic acid and it is proposed that the inhibitor blocksdivision by interfering with essential changes in the phosphorylationstate of proteins at mitosis. This conclusion is discussed inrelation to genetical and biochemical evidence that proteinkinases and phosphatases are involved in the cell division ofplants and other eukaryotes. (Received November 26, 1991; Accepted April 20, 1992)     

Biochemical and Histochemical Studies on Catecholamines in Bullfrog Spinal Ganglia

Abstract: Bullfrog spinal ganglia were subjected to two types of examination to determine whether catecholamines were present. A biochemical microassay developed by Kissinger and co-workers and a histofluorescence technique for cellular demonstration of biogenic monoamines developed earlier by Falck and co-workers were used. Bullfrog spinal ganglia and dorsal roots were found to contain catecholamines, primarily adrenaline.     

α-methyl-6-aminodopamine: Depletion of catecholamines in mouse brain and peripheral tissues

A new synthetic agent R, S-2-amino-1(2-amino-4, 5-dihydroxyphenyl) propane dihydrobromide, also referred to as α-methyl-6-aminodopamine (α-Me-6-ADA), has been found to produce acute (one day) and longer-term (seven day) depletion of norepinephrine (NE) levels in mouse brain and peripheral tissues. A 100 mg/kg dose of α-Me-6-ADA (i.v., free base) produced greater than 85% depletion of NE in the heart and spleen at one day and one week after treatment. Intracranially, α-Me-6-ADA (100 μg i.vtr.) depleted NE in the telencephalon and brain stem by 79% and 21% respectively at seven days. In addition DA was depleted by 45% in the ipsilateral striatum. The α-Me-6-ADA appears to have a relative selectivity for noradrenergic nerves, as an intracranial dose of 10 μg, which decreased NE in mouse whole brain by 52% at one day, failed to alter the DA content. These data suggest that α-Me-6-ADA may be a neurotoxin.